⌘K

Cadrenal Therapeutics, Inc. (CVKD)

$11.03 8.07% $0.82 Healthcare

Cadrenal Therapeutics, Inc. operates as a clinical development biopharmaceutical company. The company focuses on developing Tecarfarin, a novel therapy with orphan drug indication for the prevention of systemic thromboembolism of cardiac origin in patients with end-stage renal disease and atrial fibrillation. The company was incorporated in 2022 and is headquartered in Ponte Vedra, Florida.

Market cap

$11.77M

CEO

Mr. Quang Pham

Full time employees

1.00

Headquarters

Ponte Vedra, FL

IPO Date

Jan 20, 2023

Price-to-earnings (PE) Ratio

-2.30

Earnings-per-share (EPS)

$-4.80

Cash ratio (TTM)

7.67

Current ratio (TTM)

8.01

Net profit margin (TTM)

-175,101.16%

PE ratio (TTM)

-1.49

PEG ratio (TTM)

-0.01

Price-to-book ratio (TTM)

1.17

Price-to-sales ratio (TTM)

2,616.41

Quick ratio (TTM)

7.67

Return on assets (TTM)

-68.76%

Return on equity (TTM)

-75.13%

Similar stocks (16)

Structure Therapeutics Inc.

GPCR

$40.15 -1.68% $-0.69

Downtrend

Eliem Therapeutics, Inc.

ELYM

$8.24 -2.60% $-0.22

Uptrend

Foghorn Therapeutics Inc.

FHTX

$9.23 -5.04% $-0.49

Uptrend

Nuvectis Pharma, Inc.

NVCT

$6.34 -4.95% $-0.33

Downtrend

Ikena Oncology, Inc.

IKNA

$1.72 1.78% $0.03

Uptrend

PMV Pharmaceuticals, Inc.

PMVP

$1.52 0.33% $0.00

Downtrend

Anebulo Pharmaceuticals, Inc.

ANEB

$2.09 0.00% $0.00

Downtrend

ZIVO Bioscience, Inc.

ZIVO

$12.00 1.69% $0.20

Uptrend

AN2 Therapeutics, Inc.

ANTX

$1.04 0.48% $0.00

Downtrend

SAB Biotherapeutics, Inc.

SABS

$2.79 1.09% $0.03

Downtrend

HCW Biologics Inc.

HCWB

$0.60 -3.54% $-0.02

Downtrend

Monopar Therapeutics Inc.

MNPR

$4.32 11.96% $0.46

Neutral

Senti Biosciences, Inc.

SNTI

$3.04 -1.14% $-0.04

Downtrend

Inhibikase Therapeutics, Inc.

IKT

$1.17 -0.85% $-0.01

Downtrend

Exicure, Inc.

XCUR

$2.12 32.70% $0.52

Downtrend

Quoin Pharmaceuticals, Ltd.

QNRX

$0.63 4.69% $0.03

Downtrend

ETF Exposure (2)

Vanguard Extended Market Index Fund Institutional Shares

VIEIX

$134.52 1.86% $2.45

Uptrend

Vanguard Extended Market Index Fund

VXF

$178.21 0.46% $0.82

Uptrend

Neutral

Similar stocks (16)

Structure Therapeutics Inc.

GPCR

$40.15 -1.68% $-0.69

Downtrend

Eliem Therapeutics, Inc.

ELYM

$8.24 -2.60% $-0.22

Uptrend

Foghorn Therapeutics Inc.

FHTX

$9.23 -5.04% $-0.49

Uptrend

Nuvectis Pharma, Inc.

NVCT

$6.34 -4.95% $-0.33

Downtrend

Ikena Oncology, Inc.

IKNA

$1.72 1.78% $0.03

Uptrend

PMV Pharmaceuticals, Inc.

PMVP

$1.52 0.33% $0.00

Downtrend

Anebulo Pharmaceuticals, Inc.

ANEB

$2.09 0.00% $0.00

Downtrend

ZIVO Bioscience, Inc.

ZIVO

$12.00 1.69% $0.20

Uptrend

AN2 Therapeutics, Inc.

ANTX

$1.04 0.48% $0.00

Downtrend

SAB Biotherapeutics, Inc.

SABS

$2.79 1.09% $0.03

Downtrend

HCW Biologics Inc.

HCWB

$0.60 -3.54% $-0.02

Downtrend

Monopar Therapeutics Inc.

MNPR

$4.32 11.96% $0.46

Neutral

Senti Biosciences, Inc.

SNTI

$3.04 -1.14% $-0.04

Downtrend

Inhibikase Therapeutics, Inc.

IKT

$1.17 -0.85% $-0.01

Downtrend

Exicure, Inc.

XCUR

$2.12 32.70% $0.52

Downtrend

Quoin Pharmaceuticals, Ltd.

QNRX

$0.63 4.69% $0.03

Downtrend

ETF Exposure (2)

Vanguard Extended Market Index Fund Institutional Shares

VIEIX

$134.52 1.86% $2.45

Uptrend

Vanguard Extended Market Index Fund

VXF

$178.21 0.46% $0.82

Uptrend